MoonLake Immunotherapeutics MLTX
NASDAQ MLTX
$11.41 -0.06 (-0.52%)
At close: Oct 2, 2026 · 4:00 PM EDT

MoonLake Immunotherapeutics (MLTX) Selling, General & Administrative (2021 - 2026)

Updated

MoonLake Immunotherapeutics' Selling, General & Administrative came in at $11.44 million for Q2 2026, up 4.6% from $10.94 million a year earlier but down 26.2% from the prior quarter.

Analysis

MoonLake Immunotherapeutics (MLTX) Selling, General & Administrative (2021 - 2026) Analysis & Trends

Over the trailing twelve months to Jun 30, 2026, MoonLake Immunotherapeutics reported Selling, General & Administrative of $46.96 million, up 21.8% year-over-year; for FY2025, it was $41.97 million, up 38.4% from FY2024.

  • Selling, General & Administrative carries a five-year compound annual growth rate of 230.9% (FY2020 to FY2025).
  • Going back by year, Selling, General & Administrative was $30.32 million in FY2024 (+35.8%), $22.32 million in FY2023 (-3.0%), $23.01 million in FY2022 (+27.5%) and $18.05 million in FY2021.
  • The five-year range for quarterly Selling, General & Administrative is $4.48 million (Q2 2023) to $15.51 million (Q1 2026).
  • Year-over-year, Selling, General & Administrative increased in seven of the last eight quarters, with growth averaging 35.2%.
  • The fastest year-over-year change in Selling, General & Administrative over five years came in Q2 2022 (growth of 122.1%), and the weakest in Q4 2022 (a decline of 42.6%).
  • Business Quant data shows MLTX's Selling, General & Administrative at $15.51 million (Q1 2026), $9.21 million (Q4 2025) and $10.8 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) SG&A (Qtr)
1 Eli Lilly 1,082.65 Bn 1,051.23 Bn 19.71 Bn 3.43 Bn
2 Johnson & Johnson 623.68 Bn 542.21 Bn 17.26 Bn 6.43 Bn
3 AbbVie 459.43 Bn 432.59 Bn 12.70 Bn 3.63 Bn
4 Merck 354.80 Bn 309.23 Bn 12.21 Bn 2.90 Bn
5 Novartis Ag 269.16 Bn 225.03 Bn 11.24 Bn -3.24 Bn
6 Astrazeneca 244.40 Bn 217.97 Bn 12.86 Bn -5.65 Bn
7 Amgen 220.17 Bn 175.57 Bn 7.24 Bn 1.75 Bn
8 Gilead Sciences 183.05 Bn 157.16 Bn 6.22 Bn 1.92 Bn
9 Pfizer 160.27 Bn 107.22 Bn 10.94 Bn 3.41 Bn
10 MoonLake Immunotherapeutics 976.17 Mn -693.22 Mn - 11.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.44 Mn
Mar 31, 2026 15.51 Mn
Dec 31, 2025 9.21 Mn
Sep 30, 2025 10.80 Mn
Jun 30, 2025 10.94 Mn
Mar 31, 2025 11.03 Mn
Dec 31, 2024 9.22 Mn
Sep 30, 2024 7.38 Mn
Jun 30, 2024 6.92 Mn
Mar 31, 2024 6.81 Mn
Dec 31, 2023 6.93 Mn
Sep 30, 2023 5.39 Mn
Jun 30, 2023 4.48 Mn
Mar 31, 2023 5.52 Mn
Dec 31, 2022 5.33 Mn
Sep 30, 2022 5.75 Mn
Jun 30, 2022 6.25 Mn
Mar 31, 2022 5.49 Mn
Dec 31, 2021 9.28 Mn
Sep 30, 2021 5.60 Mn
API Access

MoonLake Immunotherapeutics Selling, General & Administrative API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=MLTX&period=max&api_key=YOUR_API_KEY